When to stop immune checkpoint inhibitor for malignant melanoma? Challenges in emulating target trials

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.

When to stop immune checkpoint inhibitor for malignant melanoma? Challenges in emulating target trials - World Wide